Linike Medical Group Ltd.
LNMG
$0.0061
$0.00011.67%
OTC PK
| 07/31/2014 | 04/30/2014 | 01/31/2014 | 10/31/2013 | 07/31/2013 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 93.70K | 142.60K | 201.70K | 214.50K | 274.30K |
| Depreciation & Amortization | 210.20K | 210.30K | 210.80K | 210.80K | 600.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 303.90K | 352.90K | 412.50K | 425.30K | 274.90K |
| Operating Income | -303.90K | -352.90K | -412.50K | -425.30K | -274.90K |
| Income Before Tax | -306.90K | -358.30K | -415.10K | -427.90K | -276.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.31 | -0.36 | -0.42 | -0.43 | -0.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -306.90K | -358.30K | -415.10K | -427.90K | -276.70K |
| EBIT | -303.90K | -352.90K | -412.50K | -425.30K | -274.90K |
| EBITDA | -303.20K | -352.30K | -411.80K | -373.80K | -139.20K |
| EPS Basic | -0.11 | -0.15 | -0.19 | -0.31 | -0.53 |
| Normalized Basic EPS | -0.07 | -0.09 | -0.12 | -0.19 | -0.33 |
| EPS Diluted | -0.11 | -0.15 | -0.19 | -0.31 | -0.53 |
| Normalized Diluted EPS | -0.07 | -0.09 | -0.12 | -0.19 | -0.33 |
| Average Basic Shares Outstanding | 13.05M | 11.15M | 9.25M | 6.16M | 3.80M |
| Average Diluted Shares Outstanding | 13.05M | 11.15M | 9.25M | 6.16M | 3.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |